Mehran Zarghami
Overview
Explore the profile of Mehran Zarghami including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
436
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Savari E, Nasirpour N, Rahimi-Movaghar A, Hajebi A, Sharifi V, Amin-Esmaeili M, et al.
BMC Psychiatry
. 2025 Feb;
25(1):111.
PMID: 39934696
Background: Social capital has long been recognized as a determinant of various health outcomes. However, the existence and magnitude of these associations may vary across different health conditions, different communities,...
2.
Enderami A, Shariati B, Zarghami M, Aliasgharian A, Ghazaiean M, Darvishi-Khezri H
Neuropsychopharmacol Rep
. 2025 Jan;
45(1):e12528.
PMID: 39871536
Contradictory results for the association between metformin intake and changes in cognitive function have been reported. We attempted to overview systematic reviews and meta-analyses showing the role of metformin, as...
3.
Zarghami M
Children (Basel)
. 2025 Jan;
11(12.
PMID: 39767968
Recently, an article entitled "Atomoxetine Treatment of Attention Deficit/Hyperactivity Disorder Symptoms in 3-6-Year-Old Children with Autism Spectrum Disorder: A Retrospective Cohort Study" was published in the journal . In this...
4.
Lye M, Zarghami M, Abdollahi F
Oman Med J
. 2024 Jan;
38(5):e563.
PMID: 38192362
No abstract available.
5.
Zarghami M, Kharazmi O, Alipour A, Babakhanian M, Khosravi A, Mirtorabi S
Addict Health
. 2023 Nov;
15(3):149-155.
PMID: 38026723
Background: Investigating the temporal variations and forecasting the trends in drug-related deaths can help prevent health problems and develop intervention programs. The recent policy in Iran is strongly focused on...
6.
Elyasi F, Zarghami M, Fariborzifar A, Cheraghmakani H, Shirzad M, Kazempour F
Clin Case Rep
. 2023 Aug;
11(8):e7734.
PMID: 37546158
Key Clinical Message: In some patients, neuroleptic malignant syndrome is accompanied significant high levels of erythrocyte sedimentation rate (ESR), C-reactive protein (CRP). Abstract: Neuroleptic malignant syndrome (NMS) is an idiosyncratic...
7.
Dolatshahi B, Naderi Rajeh Y, Pourshahbaz A, Zarghami M
Iran J Psychiatry
. 2023 Jun;
18(2):165-172.
PMID: 37383958
Research has demonstrated that individuals with a history of depression engage in complicated strategies (e.g., thought suppression) that may mask the possible existence of major depression. Increasing the mental strain,...
8.
Alizadeh Arimi F, Zarghami M, Moosazadeh M, Mehravaran H, Sedighi F, Ghasemian R, et al.
Clin Respir J
. 2023 Apr;
17(5):414-428.
PMID: 37054699
Background And Aim: Delirium has been presented as the leading cause of sudden change in the mental state of patients with coronavirus disease 2019 (COVID-19). Given that the delayed diagnosis...
9.
Sedighi F, Zarghami M, Alizadeh Arimi F, Moosazadeh M, Ala S, Ghasemian R, et al.
Neuropsychopharmacol Rep
. 2023 Mar;
43(2):202-212.
PMID: 36941089
Introduction: Selective serotonin reuptake inhibitors are considered the drugs, whose effectiveness in viral pandemics has been studied. The aim of this study was to evaluate of adding fluoxetine to the...
10.
Lye M, Zarghami M, Yazdani Charati J, Abdollahi F
Oman Med J
. 2023 Mar;
38(1):e464.
PMID: 36937772
Objectives: This study aimed to determine the prevalence of different types of intimate partner violence (IPV) experienced by married Iranian women and their impact on the growth and development of...